GlassScriptPhysician profile
Jennifer Lopez
NPI 1972324523
$943.84
in general payments reported to CMS, 2019-2025
15 companies · $944 in 2025
The $944 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.85 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $201.91 | 2025 | Tremfya |
| Ucb, INC. | $180.93 | 2025 | Bimzelx |
| Genzyme Corporation | $175.76 | 2025 | |
| Incyte Corporation | $69.27 | 2025 | Opzelura |
| Abbvie INC. | $67.09 | 2025 | |
| Arcutis Biotherapeutics, INC. | $56.23 | 2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $43.90 | 2025 | |
| Lilly USA, LLC | $42.76 | 2025 | Ebglyss |
| Leo Pharma INC. | $28.38 | 2025 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $20.07 | 2025 | Libtayo |
| Lnhc, INC | $19.09 | 2025 | Zelsuvmi |
| Galderma Laboratories, L.P. | $16.04 | 2025 | Nemluvio |
| Sanofi-Aventis U.S. LLC | $14.39 | 2025 | |
| Organon LLC | $6.02 | 2025 | |
| Mayne Pharma Commercial LLC | $2.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.